As Sunil Verma and associates note, evidence is rapidly accumulating that aromatase
inhibitors offer advantages over tamoxifen in terms of efficacy and toxicity. 1-3 However …

As the Steering Committee on Clinical Practice Guidelines for the Care and Treatment of
Breast Cancer points out, 1 locally advanced breast cancer comprises a heterogeneous …

For a long time the quest for the extra month of survival dominated the field of medical
oncology. One will certainly not deny the significance of this factor; but while several months …

The potential goals of neoadjuvant treatment for locally advanced breast cancer (LABC)
include downsizing tumors to allow breast conservation as well as the possibility of …

Background In the UK breast cancer affects one in 9 women during their lifetime, and causes
about 21,000 deaths per year (Quinn et al, 2001). Prevalence is about five times higher, with …

Breast cancer remains the commonest malignancy amongst women and its incidence
continues to increase worldwide. This inexorable rise in numbers of women suffering from …

Using aromatase inhibitors to treat eariy breast cancer Page 1 Using aromatase inhibitors to
treat eariy breast cancer By Leon Speroff, MD Aromatase inhibitors have surpassed tamoxifen …

Time for a change in breast cancer therapy? Page 1 REVIEW David Cameron The first evidence
has now appeared that the improvement in breast cancer recurrence rates can translate into …

The large number of excellent presentations on breast cancer at this year's ASCO meeting
reflects the enormous interest in clinical trials of this common disease. In the reports of …

In summarym AI should become an integral part of the overall treatment of post-menopausal
women with hormone receptor-positive early breast cancer, based on their consistent …